Glucagon nasal powder

A promising alternative to intramuscular glucagon in youth with type 1 diabetes

T1D Exchange Intranasal Glucagon Investigators

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Objective Treatment of severe hypoglycemia outside of the hospital setting is limited to intramuscular glucagon requiring reconstitution prior to injection. The current study examined the safety and dose-response relationships of a needle-free intranasal glucagon preparation in youth aged 4 to

Original languageEnglish (US)
Pages (from-to)555-562
Number of pages8
JournalDiabetes Care
Volume39
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Glucagon
Type 1 Diabetes Mellitus
Nose
Powders
Hypoglycemia
Needles
Safety
Injections
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Glucagon nasal powder : A promising alternative to intramuscular glucagon in youth with type 1 diabetes. / T1D Exchange Intranasal Glucagon Investigators.

In: Diabetes Care, Vol. 39, No. 4, 01.04.2016, p. 555-562.

Research output: Contribution to journalArticle

T1D Exchange Intranasal Glucagon Investigators. / Glucagon nasal powder : A promising alternative to intramuscular glucagon in youth with type 1 diabetes. In: Diabetes Care. 2016 ; Vol. 39, No. 4. pp. 555-562.
@article{4cb86c652ac64812b62c468308660553,
title = "Glucagon nasal powder: A promising alternative to intramuscular glucagon in youth with type 1 diabetes",
abstract = "Objective Treatment of severe hypoglycemia outside of the hospital setting is limited to intramuscular glucagon requiring reconstitution prior to injection. The current study examined the safety and dose-response relationships of a needle-free intranasal glucagon preparation in youth aged 4 to",
author = "{T1D Exchange Intranasal Glucagon Investigators} and Sherr, {Jennifer L.} and Ruedy, {Katrina J.} and Foster, {Nicole C.} and Pich{\'e}, {Claude A.} and H{\'e}l{\`e}ne Dulude and Rickels, {Michael R.} and Tamborlane, {William V.} and Bethin, {Kathleen E.} and Linda DiMeglio and Fox, {Larry A.} and Wadwa, {R. Paul} and Schatz, {Desmond A.} and Nathan, {Brandon M.} and Marcovina, {Santica M.} and Emmanouil Rampakakis and Linyan Meng and Beck, {Roy W.}",
year = "2016",
month = "4",
day = "1",
doi = "10.2337/dc15-1606",
language = "English (US)",
volume = "39",
pages = "555--562",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Glucagon nasal powder

T2 - A promising alternative to intramuscular glucagon in youth with type 1 diabetes

AU - T1D Exchange Intranasal Glucagon Investigators

AU - Sherr, Jennifer L.

AU - Ruedy, Katrina J.

AU - Foster, Nicole C.

AU - Piché, Claude A.

AU - Dulude, Hélène

AU - Rickels, Michael R.

AU - Tamborlane, William V.

AU - Bethin, Kathleen E.

AU - DiMeglio, Linda

AU - Fox, Larry A.

AU - Wadwa, R. Paul

AU - Schatz, Desmond A.

AU - Nathan, Brandon M.

AU - Marcovina, Santica M.

AU - Rampakakis, Emmanouil

AU - Meng, Linyan

AU - Beck, Roy W.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Objective Treatment of severe hypoglycemia outside of the hospital setting is limited to intramuscular glucagon requiring reconstitution prior to injection. The current study examined the safety and dose-response relationships of a needle-free intranasal glucagon preparation in youth aged 4 to

AB - Objective Treatment of severe hypoglycemia outside of the hospital setting is limited to intramuscular glucagon requiring reconstitution prior to injection. The current study examined the safety and dose-response relationships of a needle-free intranasal glucagon preparation in youth aged 4 to

UR - http://www.scopus.com/inward/record.url?scp=84962081607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962081607&partnerID=8YFLogxK

U2 - 10.2337/dc15-1606

DO - 10.2337/dc15-1606

M3 - Article

VL - 39

SP - 555

EP - 562

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 4

ER -